loadpatents
Patent applications and USPTO patent grants for Drevets; Wayne C..The latest application filed is for "methods of treating depression using orexin-2 receptor antagonists".
Patent | Date |
---|---|
Methods for the treatment of depression Grant 11,311,500 - Caers , et al. April 26, 2 | 2022-04-26 |
Methods Of Treating Depression Using Orexin-2 Receptor Antagonists App 20220105094 - De Boer; Peter ;   et al. | 2022-04-07 |
Compositions and methods for the treatment of depression Grant 11,266,627 - Schmidt , et al. March 8, 2 | 2022-03-08 |
Methods of treating depression using orexin-2 receptor antagonists Grant 11,241,432 - De Boer , et al. February 8, 2 | 2022-02-08 |
Methods for the treatment of depression Grant 11,173,134 - Caers , et al. November 16, 2 | 2021-11-16 |
Methods For The Treatment Of Depression App 20210308076 - Caers; Lodewijk Ivo ;   et al. | 2021-10-07 |
Methods For The Treatment Of Depression App 20210106545 - Caers; Lodewijk Ivo ;   et al. | 2021-04-15 |
Methods Of Treating Depression Using Orexin-2 Receptor Antagonists App 20210052588 - De Boer; Peter ;   et al. | 2021-02-25 |
Methods for the treatment of depression Grant 10,869,844 - Caers , et al. December 22, 2 | 2020-12-22 |
Methods of treating depression using orexin-2 receptor antagonists Grant 10,828,302 - De Boer , et al. November 10, 2 | 2020-11-10 |
Method for the treatment of depression Grant 10,098,854 - Drevets , et al. October 16, 2 | 2018-10-16 |
Methods Of Treating Depression Using Orexin-2 Receptor Antagonists App 20170258790 - De Boer; Peter ;   et al. | 2017-09-14 |
Scopolamine for the treatment of depression and anxiety Grant 9,707,220 - Furey , et al. July 18, 2 | 2017-07-18 |
Method For The Treatment Of Depression App 20160045455 - Drevets; Wayne C. ;   et al. | 2016-02-18 |
Scopolamine For The Treatment Of Depression And Anxiety App 20140378501 - Furey; Maura L. ;   et al. | 2014-12-25 |
Scopolamine for the treatment of depression and anxiety Grant 8,859,585 - Furey , et al. October 14, 2 | 2014-10-14 |
Scopolamine for the treatment of depression and anxiety App 20060270698 - Furey; Maura L. ;   et al. | 2006-11-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.